Ceesay Abraham's Form 4 filing
Rapport Therapeutics, Inc. (RAPP) · filed Dec 18, 2025
- Accession no.
- 0001193125-25-324826
- Filed
- Dec 18, 2025
- Trade date
- Dec 17, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $323.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ceesay AbrahamCIK 0001722140 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Common Stock | SSaleDisposed | −2,441 | $28.84 | −$70,398.44 | 571,305 | Direct | |
| Dec 17, 2025 | Common Stock | SSaleDisposed | −2,792 | $30.04 | −$83,871.68 | 568,513 | Direct | |
| Dec 17, 2025 | Common Stock | SSaleDisposed | −600 | $31.04 | −$18,624 | 567,913 | Direct | |
| Dec 17, 2025 | Common Stock | SSaleDisposed | −2,147 | $28.84 | −$61,919.48 | 33,831 | Indirect | |
| Dec 17, 2025 | Common Stock | SSaleDisposed | −2,421 | $30.04 | −$72,726.84 | 31,410 | Indirect | |
| Dec 17, 2025 | Common Stock | SSaleDisposed | −515 | $31.04 | −$15,985.6 | 30,895 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.